Patricia Nahirya Ntege

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial”.

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

The Lancet(2022)10.1016/s0140-6736(22)00538-4

N/A

7.4DataRank · unranked

552 citations

James P. Hughes, Peter Bock, Samuel Gurrion Ouma, Portia Hunidzarira, Dishiki Kalonji +95 more

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00263-1

N/A

0.750DataRank · unranked

24 citations

Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen +95 more

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

UNC Libraries(2023)10.17615/9m9q-rf23

N/A

0DataRank · unranked

0 citations

Bekezela Siziba, Dishiki Kalonji, M.C. Hosseinipour, S. Delany-Moretlwe, C.W. Hendrix +35 more

Human Papillomavirus Vaccination Among Adolescent Girls in a Ugandan HIV Clinic: A Cross‐Sectional Survey

Reproductive Female and Child Health(2025)10.1002/rfc2.70023

N/A

0DataRank · unranked

1 citations

Jacqueline Balungi Kanywa, Patricia Nahirya Ntege, Greta L. Becker, Linder Wendt, J. Brooks Jackson +2 more